JP2021102605A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021102605A5 JP2021102605A5 JP2020208924A JP2020208924A JP2021102605A5 JP 2021102605 A5 JP2021102605 A5 JP 2021102605A5 JP 2020208924 A JP2020208924 A JP 2020208924A JP 2020208924 A JP2020208924 A JP 2020208924A JP 2021102605 A5 JP2021102605 A5 JP 2021102605A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- acceptable salt
- amoxicillin
- bacterial infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025130486A JP2025163188A (ja) | 2019-12-20 | 2025-08-05 | マイコバクテリア感染症を治療するための、アモキシシリン誘導体とアビバクタム誘導体の組み合わせ経口投与 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962951187P | 2019-12-20 | 2019-12-20 | |
| US62/951,187 | 2019-12-20 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025130486A Division JP2025163188A (ja) | 2019-12-20 | 2025-08-05 | マイコバクテリア感染症を治療するための、アモキシシリン誘導体とアビバクタム誘導体の組み合わせ経口投与 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021102605A JP2021102605A (ja) | 2021-07-15 |
| JP2021102605A5 true JP2021102605A5 (https=) | 2023-12-20 |
Family
ID=73856245
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020208924A Pending JP2021102605A (ja) | 2019-12-20 | 2020-12-17 | マイコバクテリア感染症を治療するための、アモキシシリン誘導体とアビバクタム誘導体の組み合わせ経口投与 |
| JP2025130486A Pending JP2025163188A (ja) | 2019-12-20 | 2025-08-05 | マイコバクテリア感染症を治療するための、アモキシシリン誘導体とアビバクタム誘導体の組み合わせ経口投与 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025130486A Pending JP2025163188A (ja) | 2019-12-20 | 2025-08-05 | マイコバクテリア感染症を治療するための、アモキシシリン誘導体とアビバクタム誘導体の組み合わせ経口投与 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20210186983A1 (https=) |
| EP (1) | EP4076451A1 (https=) |
| JP (2) | JP2021102605A (https=) |
| KR (1) | KR20220114629A (https=) |
| CN (1) | CN115003302A (https=) |
| AU (1) | AU2020405540A1 (https=) |
| CA (1) | CA3164938A1 (https=) |
| WO (1) | WO2021124191A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119841826B (zh) * | 2024-09-30 | 2026-04-10 | 科睿迪(南京)医药科技有限公司 | 二氮杂二环类β-内酰胺酶抑制剂及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10085999B1 (en) * | 2017-05-10 | 2018-10-02 | Arixa Pharmaceuticals, Inc. | Beta-lactamase inhibitors and uses thereof |
| JP2022524118A (ja) * | 2019-03-12 | 2022-04-27 | アリクサ ファーマシューティカルズ、インコーポレイテッド | アビバクタム誘導体の結晶形 |
-
2020
- 2020-12-16 US US17/123,858 patent/US20210186983A1/en not_active Abandoned
- 2020-12-17 EP EP20828353.1A patent/EP4076451A1/en not_active Withdrawn
- 2020-12-17 CA CA3164938A patent/CA3164938A1/en active Pending
- 2020-12-17 CN CN202080088738.1A patent/CN115003302A/zh active Pending
- 2020-12-17 KR KR1020227024569A patent/KR20220114629A/ko not_active Withdrawn
- 2020-12-17 JP JP2020208924A patent/JP2021102605A/ja active Pending
- 2020-12-17 AU AU2020405540A patent/AU2020405540A1/en not_active Abandoned
- 2020-12-17 WO PCT/IB2020/062099 patent/WO2021124191A1/en not_active Ceased
-
2024
- 2024-03-27 US US18/618,149 patent/US20240245705A1/en active Pending
-
2025
- 2025-08-05 JP JP2025130486A patent/JP2025163188A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Colin et al. | Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus | |
| ES2306146T3 (es) | Uso de derivados de quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a farmacos. | |
| Shulha et al. | Pharmacotherapy approaches in nontuberculous mycobacteria infections | |
| Gan et al. | Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial | |
| JP2019522039A5 (https=) | ||
| CA2936714A1 (en) | Combinations comprising zidovudine, a polymyxin and an anti-tuberculosis antibiotic and uses thereof | |
| JP2018507243A5 (https=) | ||
| AU2025234215A1 (en) | Methods of treating mycobacterial infections using tetracycline compounds | |
| KR101307650B1 (ko) | 구역에 대한 경피 방법 및 패치 | |
| JP2016505050A5 (https=) | ||
| WO2018004576A3 (en) | A fast acting orally disintegrating film for administration of local anesthesia | |
| JP2021102605A5 (https=) | ||
| Helm et al. | Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model | |
| JP2021517128A5 (https=) | ||
| TW201615182A (zh) | 含有多奈哌齊（ｄｏｎｅｐｅｚｉｌ）的經皮藥物傳輸系統 | |
| CN110831592A (zh) | 医药 | |
| Asif | Antimicrobial and anti-tubercular activity of quinolone analogues | |
| CN101180018B (zh) | 用于治疗恶心的经皮的方法和贴片 | |
| Hu et al. | Comparison of topical antibiotics for treating Mycobacterium chelonae keratitis in a rabbit model | |
| TW202233168A (zh) | 治療非結核分枝桿菌疾病的藥物組分之組合 | |
| US20050227949A1 (en) | Compositions and methods for treatment of viral and bacterial infections | |
| CN114641305A (zh) | 用于非结核分枝杆菌疾病的抗生素增效 | |
| WO2021188326A1 (en) | Sphingosine pathway modulating compounds for the treatment of coronavirus infection | |
| EP4422616A1 (en) | Human efficacious dose and dosage schedule of spr720 | |
| US20230028539A1 (en) | Pharmaceutical composition, complementary kit and application thereof |